欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DK/H/1840/003
药品名称
Lambrinex
活性成分
atorvastatin calcium salt 40.0 mg
剂型
Film-coated tablet
上市许可持有人
Pharmathen S.A. Dervenakion 6 153 51 Pallini Greece
参考成员国 - 产品名称
Denmark (DK)
Lambrinex
互认成员国 - 产品名称
United Kingdom (Northern Ireland) (XI)
Greece (GR)
Cyprus (CY)
LAMBRINEX 40mg FC TABS
许可日期
2011/01/19
最近更新日期
2023/11/17
药物ATC编码
C10AA05 atorvastatin
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
Atorvastatin 1840_IA025 var_ common_PIL_clean
Date of last change:2023/11/17
Final SPC
|
Atorvastatin 1840_IA025 var_ common_SPC_clean
Date of last change:2023/11/17
Final Product Information
|
1840-common-pl-clean
Date of last change:2019/07/19
Final Labelling
|
common-pl-clean-ib016
Date of last change:2018/09/20
Final Labelling
|
common-spc-clean-ib016
Date of last change:2018/09/20
Final Labelling
|
common-outer-clean-ib016
Date of last change:2018/09/20
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase